Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 540,099 | 380,833 | 301,034 | 154,584 | 5,421 |
| Cost of Goods | 63,382 | 56,586 | 34,193 | 7,353 | 101 |
| Gross Profit | 476,717 | 324,247 | 266,841 | 147,231 | 5,320 |
| Operating Expenses | 1,041,262 | 1,030,396 | 610,662 | 319,222 | 272,151 |
| Operating Income | -564,163 | -705,563 | -343,628 | -171,638 | -266,730 |
| Interest Expense | 0 | 0 | 0 | 0 | 535 |
| Other Income | 11,098 | -8,317 | -18,982 | 123,010 | 0 |
| Pre-tax Income | -553,065 | -713,880 | -362,610 | -48,628 | -267,265 |
| Income Tax | 1,063 | 1,195 | -692 | 2,060 | 0 |
| Net Income Continuous | -554,128 | -715,075 | -361,918 | -50,688 | -267,265 |
| Net Income | $-554,128 | $-715,075 | $-361,918 | $-50,688 | $-267,265 |
| EPS Basic Total Ops | -7.11 | -9.71 | -5.46 | -0.86 | -5.49 |
| EPS Basic Continuous Ops | -7.11 | -9.71 | -5.46 | -0.86 | -5.49 |
| EPS Diluted Total Ops | -7.11 | -9.71 | -5.46 | -0.86 | -5.49 |
| EPS Diluted Continuous Ops | -7.11 | -9.71 | -5.46 | -0.86 | -5.49 |
| EPS Diluted Before Non-Recurring Items | -7.11 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-537,252 | $-681,063 | $-339,055 | $-164,434 | $-261,039 |